Qube Research & Technologies LTD Bioventus Inc. Transaction History
Qube Research & Technologies LTD
- $72.9 Billion
- Q4 2024
A detailed history of Qube Research & Technologies LTD transactions in Bioventus Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 254,029 shares of BVS stock, worth $2.29 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
254,029
Previous 145,548
74.53%
Holding current value
$2.29 Million
Previous $1.74 Million
53.36%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BVS
# of Institutions
159Shares Held
45.3MCall Options Held
252KPut Options Held
72.5K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$118 Million31.61% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$62.7 Million28.32% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.03MShares$36.4 Million2.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.46MShares$22.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$21.4 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $557M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...